Compare Norfolk Southern Corporation (NSC) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Norfolk Southern Corporation vs State Street SPDR S&P Biotech ETF — how do they compare? Norfolk Southern Corporation trades at $333 (market cap $75.23B), while State Street SPDR S&P Biotech ETF trades at $154.43. The key difference: Norfolk Southern Corporation pays a 1.61% dividend while State Street SPDR S&P Biotech ETF pays none. Which is the better fit depends on your goals.
| NSC | XBI | |
|---|---|---|
Market Cap | $75.23B | — |
Sector | Technology | Broad Market / Factor |
52-Week High | $340.16 | $164.28 |
52-Week Low | $272.35 | $85.16 |
Enterprise Value | $90.99B | — |
Dividend Yield | 1.61% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Norfolk Southern Corporation
Norfolk Southern Corporation is a major North American railroad company operating one of the largest freight rail networks in the eastern United States. The company transports a diverse range of commodities, including coal, intermodal containers, and various industrial products. NSC is a critical link in the nation's supply chain, providing efficient, long-haul transportation services to and from ports and industrial centers.
Read more on NSC →About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →
